Community Trust & Investment Co. Trims Stock Position in CVS Health Corporation $CVS

Community Trust & Investment Co. decreased its position in CVS Health Corporation (NYSE:CVS) by 3.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 253,525 shares of the pharmacy operator’s stock after selling 7,993 shares during the period. Community Trust & Investment Co.’s holdings in CVS Health were worth $19,113,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the business. Forza Wealth Management LLC raised its position in CVS Health by 6.6% in the third quarter. Forza Wealth Management LLC now owns 9,585 shares of the pharmacy operator’s stock valued at $723,000 after purchasing an additional 596 shares during the period. Robeco Institutional Asset Management B.V. increased its position in shares of CVS Health by 16.2% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 3,095,243 shares of the pharmacy operator’s stock worth $233,350,000 after purchasing an additional 432,132 shares during the last quarter. D.A. Davidson & CO. raised its holdings in CVS Health by 1.8% in the 3rd quarter. D.A. Davidson & CO. now owns 208,489 shares of the pharmacy operator’s stock valued at $15,718,000 after buying an additional 3,728 shares during the period. Motco lifted its position in CVS Health by 297.6% in the third quarter. Motco now owns 1,348 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 1,009 shares during the last quarter. Finally, Daymark Wealth Partners LLC boosted its stake in CVS Health by 1.1% during the third quarter. Daymark Wealth Partners LLC now owns 28,830 shares of the pharmacy operator’s stock worth $2,173,000 after buying an additional 306 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CVS has been the topic of several recent analyst reports. Wall Street Zen lowered shares of CVS Health from a “buy” rating to a “hold” rating in a report on Saturday, November 1st. Evercore ISI upped their price target on CVS Health from $85.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, October 30th. Sanford C. Bernstein lifted their price objective on CVS Health from $86.00 to $87.00 and gave the company a “market perform” rating in a research note on Friday, December 12th. Cantor Fitzgerald reissued an “overweight” rating on shares of CVS Health in a research note on Wednesday, December 10th. Finally, Leerink Partners raised their target price on CVS Health from $86.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, October 16th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $94.67.

CVS Health Trading Up 0.2%

CVS opened at $80.32 on Tuesday. The business has a fifty day moving average price of $78.63 and a 200 day moving average price of $73.55. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. CVS Health Corporation has a 12 month low of $44.92 and a 12 month high of $85.15. The stock has a market capitalization of $101.96 billion, a price-to-earnings ratio of 211.37, a PEG ratio of 0.74 and a beta of 0.48.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. The company had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Sell-side analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.